TITLE

The management of atrial fibrillation in elderly patients

AUTHOR(S)
Hampton, John R.
PUB. DATE
May 1999
SOURCE
Age & Ageing;May99, Vol. 28 Issue 3, p248
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Describes atrial fibrillation. Causes; Drug therapy for atrial fibrillation; Stroke association with atrial fibrillation.
ACCESSION #
1925506

 

Related Articles

  • Rhythm-control strategies were not better than rate-control strategies in atrial fibrillation. Silver, Alan // ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p36 

    Presents a study that compared the effectiveness of long-term rate-control treatment strategy with a rhythm-control treatment strategy for atrial fibrillation. Design; Intervention; Outcome measures; Results; Commentary.

  • Is a single oral dose of amiodarone safe and effective in converting new-onset atrial fibrillation (AF) to sinus rhythm? DeSimone, Kristin Lengle // Journal of Family Practice;Jun2000, Vol. 49 Issue 6, p493 

    The article discusses research being done on the effectiveness of amiodarone in the treatment of atrial fibrillation (AF), with reference to a study by K. Peuhkurinen, M. Niemela, A. Ylitalo, et al., which appeared in the 2000 issue of the "American Journal of Cardiology." Patients included in...

  • Valsartan for Atrial Fibrillation? DiMarco, John P. // Clinical Cardiology Alert;Jun2009, Vol. 28 Issue 6, p47 

    The article discusses research on the use of Valsartan for the prevention of recurrent atrial fibrillation (AF). It references a study published in the 2009 issue of the "New England Journal of Medicine." Findings from the study, which enrolled 1,442 patients, revealed that Valsartan had no...

  • Direct Thrombin Inhibitor for Atrial Fibrillation. DiMarco, John P. // Clinical Cardiology Alert;Nov2009, Vol. 28 Issue 11, p85 

    The article discusses research on the efficacy of dabigatran (DAB) and warfarin (WRF) against bleeding in patients with atrial fibrillation (AF). It references the study "Dabigatran Versus Warfarin in Patients With Atrial Fibrillation," by S. J. Connolly et al, published in a 2009 issue of the...

  • World Atrial Fibrillation Awareness Day - It's About Time! Lakkireddy, Dhanunjaya // JAFIB: Journal of Atrial Fibrillation;Oct/Nov2012, Vol. 5 Issue 3, p4 

    The author reflects on the prevalence of Atrial Fibrillation (AF) which have increased and relatively not common before the age of 60 years affecting 10% of population in the U.S. He states that coronary artery disease happens due to functional stenosis or mechanical obstruction of coronary...

  • Treatment.  // Annals of Internal Medicine;11/4/2008, Vol. 149 Issue 9, pC5.6 

    The article discusses the therapeutic management for atrial fibrillation. It relates that treatment goals for the disease include preventing stroke, reducing symptoms and preventing tachycardia-related cardiomyopathy. Rate control with calcium-channel antagonists to keep heart rate at a normal...

  • Atrial fibrillation treatment focus shifts from rhythm to rate control. Glatter, Kathryn; Herweg, Bengt; Jaffe, Charles // Patient Care;Jan2006, Vol. 40 Issue 1, p58 

    The article presents a meta-analysis of randomized clinical trials of initial therapy for atrial fibrillation (AF) comparing rhythm and rate control. It lists the reason against the use of rhythm control as first-line strategy in patients with persistent AF. It details clinical considerations...

  • Vernakalant: A novel agent for the termination of atrial fibrillation. Finnin, Miki // American Journal of Health-System Pharmacy;7/15/2010, Vol. 67 Issue 14, p1157 

    Purpose. The pharmacology, pharmacokinetics, safety, clinical efficacy, and role of intravenous vernakalant hydrochloride for the rapid conversion of atrial fibrillation (AF) to normal sinus rhythm are reviewed. Summary. Vernakalant, currently being evaluated by the Food and Drug Administration...

  • In the Clinic. Atrial Fibrillation.  // Annals of Internal Medicine;11/4/2008, Vol. 149 Issue 9, pITC5-1 

    The article discusses the therapeutic management for atrial fibrillation. It relates that treatment goals for the disease include preventing stroke, reducing symptoms and preventing tachycardia-related cardiomyopathy. Rate control with calcium-channel antagonists to keep heart rate at a normal...

  • Atrial fibrillation: New understanding, new tools.  // Patient Care;1/30/2002, Vol. 36 Issue 2, p30 

    Discusses the treatment for atrial fibrillation (AF). Treatment goals for AF; Constant threat in patients with AF; Drugs most often use for ventricular rate control. INSET: Office management of patients with AF.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics